A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway

BACKGROUND: Multidrug resistance (MDR) is the main challenge of successful chemotherapy for ovarian cancer patients, with 50% to 75% of ovarian cancer patients eventually relapsed due to it. One of the effective strategies for treating MDR and improving therapeutic efficiency of ovarian cancer is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xueqin, Xiong, Tiandi, Cui, Miao, Li, Na, Li, Qin, Zhu, Li, Duan, Shaofeng, Wang, Yunlong, Guo, Yuqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697442/
https://www.ncbi.nlm.nih.gov/pubmed/34949180
http://dx.doi.org/10.1186/s12951-021-01139-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697442/
https://www.ncbi.nlm.nih.gov/pubmed/34949180
http://dx.doi.org/10.1186/s12951-021-01139-1

Ejemplares similares